2BB score and signals
Corvus Pharmaceuticals, Inc.’s current 2BB score is 57 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 74 | High |
| Momentum | 69 | Improving |
| Financial strength | 32 | Weak |
| Quality | 63 | Strong |
| Risk | 40 | Moderate |
Company facts
| Headquarters | Burlingame, California, United States |
| Founded | 2014 |
| Employees | 37 |
| 52-week range | $6.39 – $26.95 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-10 | — | -0.2254 | — | $0.00 |
| 2026-10-29 | — | -0.204 | — | $0.00 |
| 2026-08-06 | — | -0.1619 | — | $0.00 |
| 2026-05-07 | -0.15 | -0.1457 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish